Marker Therapeutics, Inc. (MRKR)
NASDAQ: MRKR · Real-Time Price · USD
1.360
-0.050 (-3.55%)
At close: Mar 17, 2026, 4:00 PM EDT
1.398
+0.038 (2.76%)
After-hours: Mar 17, 2026, 6:28 PM EDT
Marker Therapeutics Market Cap
Marker Therapeutics has a market cap or net worth of $22.68 million as of March 17, 2026. Its market cap has increased by 65.51% in one year.
Market Cap
22.68M
Enterprise Value
5.09M
1-Year Change
65.51%
Ranking
Category
Stock Price
$1.36
Market Cap Chart
Since November 8, 2016, Marker Therapeutics's market cap has decreased from $45.80M to $22.68M, a decrease of -50.49%. That is a compound annual growth rate of -7.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 16, 2026 | 23.50M | -5.24% |
| Dec 31, 2025 | 24.80M | -10.79% |
| Dec 31, 2024 | 27.80M | -43.15% |
| Dec 29, 2023 | 48.90M | 120.27% |
| Dec 30, 2022 | 22.20M | -71.86% |
| Dec 31, 2021 | 78.90M | 13.36% |
| Dec 31, 2020 | 69.60M | -47.15% |
| Dec 31, 2019 | 131.70M | -47.70% |
| Dec 31, 2018 | 251.80M | 509.69% |
| Dec 29, 2017 | 41.30M | 27.08% |
| Dec 30, 2016 | 32.50M | -29.04% |
| Nov 8, 2016 | 45.80M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Senti Biosciences | 24.49M |
| Neuphoria Therapeutics | 24.47M |
| Vistagen Therapeutics | 24.06M |
| Passage Bio | 23.90M |
| Cue Biopharma | 22.34M |
| Skye Bioscience | 22.04M |
| Citius Pharmaceuticals | 21.53M |
| FibroBiologics | 21.12M |